DSE : ORIONPHARM

Orion Pharma Limited — Key statistics

Bangladesh

Last price 28.3 BDT (At close: Oct 29, 2026) · Market cap 6.62B

Latest research: Orion Pharma financial analysis: power revenue down 88%, BDT 25.6bn debt and a qualified audit (Oct 2026) · Orion Pharma: power revenue fell 88% after the plant contracts expired, leaving a BDT 25.6bn debt load on a pharma business earning BDT 251m

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Technical report: trend, RSI, support and resistance, charts

Key statistics

Valuation

MeasureValue
Market Cap6.62B
Enterprise Value34.93B

Dates

MeasureValue
Earnings DateNov 12, 2026
Ex-Dividend Daten/a

Shares

MeasureValue
Current Share Class234.00M
Shares Outstanding234.00M
Shares Change (YoY)n/a
Shares Change (QoQ)n/a
Owned by Insiders (%)n/a
Owned by Institutions (%)n/a
Floatn/a

Ratios

MeasureValue
PE Ration/a
Forward PEn/a
PS Ratio2.20
PB Ratio0.31
P/TBV Ratio0.33
P/FCF Ratio16.52
P/OCF Ratio8.06
PEG Ration/a

Evratios

MeasureValue
EV / Earningsn/a
EV / Sales11.60
EV / EBITDA80.09
EV / EBITn/a
EV / FCF87.16

Financialposition

MeasureValue
Current Ratio2.06
Quick Ratio1.82
Debt / Equity1.26
Debt / EBITDA63.11
Debt / FCF67.46
Interest Coverage-0.31

Financialefficiency

MeasureValue
Return on Equity (ROE)-2.98%
Return on Assets (ROA)-0.15%
Return on Invested Capital (ROIC)-0.28%
Return on Capital Employed (ROCE)-0.28%
Weighted Average Cost of Capital (WACC)1.37%
Revenue Per Employee1.02M
Profits Per Employee-201,525
Employee Count2,954
Asset Turnover0.05
Inventory Turnover1.41

Taxes

MeasureValue
Income Tax92.10M
Effective Tax Raten/a

Stockprice

MeasureValue
Beta (5Y)-0.44
52-Week Price Change-6.29%
50-Day Moving Average26.87
200-Day Moving Average27.84
Relative Strength Index (RSI)54.02
Average Volume (20 Days)680,951

Shortselling

MeasureValue
Short Interestn/a
Short Previous Monthn/a
Short % of Shares Outn/a
Short % of Floatn/a
Short Ratio (days to cover)n/a

Incomestatement

MeasureValue
Revenue3.01B
Gross Profit1.09B
Operating Income-134.87M
Pretax Income-560.80M
Net Income-595.30M
EBITDA411.29M
EBIT-134.87M
Loss Per Share-2.54

Balancesheet

MeasureValue
Cash & Cash Equivalents148.34M
Total Debt27.04B
Net Cash-26.88B
Net Cash Per Share-114.86
Equity (Book Value)21.43B
Book Value Per Share85.46
Working Capital9.00B

Cashflow

MeasureValue
Operating Cash Flow821.80M
Capital Expenditures-421.00M
Depreciation & Amortization546.16M
Net Borrowing-341.00M
Free Cash Flow400.80M
FCF Per Share1.71

Margins

MeasureValue
Gross Margin36.23%
Operating Margin-4.48%
Pretax Margin-18.62%
Profit Margin-19.77%
EBITDA Margin13.66%
EBIT Margin-4.48%
FCF Margin13.31%

Dividends

MeasureValue
Dividend Per Sharen/a
Dividend Yieldn/a
Dividend Growth (YoY)n/a
Years of Dividend Growthn/a
Payout Ration/a
FCF Payout Ration/a
Buyback Yieldn/a
Shareholder Yieldn/a
Earnings Yield-8.99%
FCF Yield6.05%

Analystforecasts

MeasureValue
Price Targetn/a
Price Target Differencen/a
Analyst Consensusn/a
Analyst Countn/a
Revenue Growth Forecast (3Y)n/a
EPS Growth Forecast (3Y)n/a

Stocksplits

MeasureValue
Last Split DateMay 27, 2013
Split TypeForward
Split Ratio1.2

Scores

MeasureValue
Altman Z-Score0.52
Piotroski F-Score4

Fairvalue

MeasureValue
Lynch Fair Valuen/a
Lynch Upsiden/a
Graham Numbern/a
Graham Upsiden/a